The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Nov. 15, 2019
Applicant:

Nitto Denko Corporation, Osaka, JP;

Inventors:

Bharat Majeti, San Diego, CA (US);

Jean-Pierre Clamme, San Diego, CA (US);

Li Wang, San Diego, CA (US);

Roger C. Adami, Carlsbad, CA (US);

Wenbin Ying, Oceanside, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/00 (2006.01); A61K 48/00 (2006.01); C12N 15/113 (2010.01); A61P 35/00 (2006.01); A61K 31/712 (2006.01); A61K 31/7125 (2006.01); A61K 9/16 (2006.01); A61K 47/24 (2006.01); A61K 9/14 (2006.01); A61K 9/19 (2006.01); A61K 47/28 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/141 (2013.01); A61K 9/1652 (2013.01); A61K 9/19 (2013.01); A61K 31/712 (2013.01); A61K 31/7125 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61P 35/00 (2018.01);
Abstract

This invention provides formulations for use in distributing RNAi molecules targeted to a human GST-π for treating a malignant tumor in a subject. The formulation can include nanoparticles composed of an ionizable lipid, a DSPE lipid, and additional lipids. A drug product can be made by lyophilization of the formulation. This invention further provides methods for ameliorating or treating a malignant tumor by administering a therapeutically effective amount of a formulation containing the RNAi agents.


Find Patent Forward Citations

Loading…